Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Theratechnologies Inc
(NQ:
THTX
)
1.350
+0.110 (+8.87%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Theratechnologies Inc
< Previous
1
2
3
Next >
Stocks That Hit 52-Week Lows On Tuesday
December 06, 2022
Tuesday's session saw 167 companies set new 52-week lows.
Via
Benzinga
Dow Drops 100 Points; Asana Shares Plummet
December 02, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday.
Via
Benzinga
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session
December 02, 2022
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.
Via
Benzinga
Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says
November 17, 2022
Via
Benzinga
Theratechnologies: Q3 Earnings Insights
October 13, 2022
Theratechnologies (NASDAQ:THTX) reported its Q3 earnings results on Thursday, October 13, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Gold Down 1%; Samsara Shares Spike Higher
December 02, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
Theratechnologies Stock Jumps After Q2 Earnings, FY22 Guidance
July 14, 2022
Via
Benzinga
Recap: Theratechnologies Q2 Earnings
July 14, 2022
Theratechnologies (NASDAQ:THTX) reported its Q2 earnings results on Thursday, July 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Dow Tumbles 300 Points After US Economy Adds 263,000 Jobs
December 02, 2022
U.S. stocks traded lower this morning, with the Dow Jones falling more than 300 points on Friday following the release of jobs data for November.
Via
Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
November 18, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Upgrades
Via
Benzinga
Earnings Scheduled For October 13, 2022
October 13, 2022
Companies Reporting Before The Bell • Valens Co (NASDAQ:VLNS) is estimated to report quarterly loss at $0.17 per share on revenue of $26.75 million.
Via
Benzinga
Earnings Preview: Theratechnologies
October 12, 2022
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Thursday, 2022-10-13. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
October 05, 2022
Losers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 04, 2022
Good morning, investor! It's time for a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday!
Via
InvestorPlace
Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday.
Via
Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 229% to $0.3688 after declining around 14% on Monday.
Via
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 10, 2022
During Wednesday, 52 stocks hit new 52-week lows.
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For July 14, 2022
July 14, 2022
Companies Reporting Before The Bell • Telefonaktiebolaget L M (NASDAQ:ERIC) is expected to report quarterly earnings at $0.16 per share on revenue of $6.45 billion.
Via
Benzinga
A Preview Of Theratechnologies's Earnings
July 13, 2022
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Thursday, 2022-07-14. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 07, 2022
Thursday's session saw 49 companies set new 52-week lows.
Via
Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
April 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal
Via
Benzinga
Theratechnologies Earnings Preview
April 12, 2022
Theratechnologies (NASDAQ:THTX) is set to give its latest quarterly earnings report on Wednesday, 2022-04-13. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion.
Via
Benzinga
Theratechnologies Q1 2022 Earnings Conference Call On April 13, 2022 At 08:30 AM ET
April 01, 2022
Theratechnologies (NASDAQ:THTX) will host a conference call at 08:30 AM ET on April 13, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
Theratechnologies Q3 Earnings Lags Consensus As Trogarzo Sales Decline
October 13, 2021
Theratechnologies Inc (NASDAQ: THTX) reported Q3 sales of $17.85 million, +27% Y/Y propelled by higher Egrifta sales of $11.22 million, +64%. The revenue missed...
Via
Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.